The association between depressive disorder and cardiac autonomic control in adults 60 years and older

Psychosomatic Medicine

Volumn 77, Issue 3, 2015, Pages 279-291

  Licht, Carmilla M M ^a   Naarding, Paul ^b   Penninx, Brenda W J H ^a   Van Der Mast, Roos C ^c   De Geus, Eco J C ^a,d   Comijs, Hannie ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GGNet ^*  (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

antidepressants; autonomic nervous system; elderly; heart rate (variability); major depressive disorder; preejection period

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CARDIAC AUTONOMIC CONTROL; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEART FUNCTION; HEART PREEJECTION PERIOD; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESPIRATORY SINUS ARRHYTHMIA; ANXIETY; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; COMORBIDITY; DEPRESSIVE DISORDER; IMPEDANCE CARDIOGRAPHY; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ANXIETY; AUTONOMIC NERVOUS SYSTEM; CARDIOGRAPHY, IMPEDANCE; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RESPIRATORY SINUS ARRHYTHMIA;

EID: 84927625136     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000165     Document Type: Article

References (77)

1. Elderon L,Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis 2013;55:511-23.
2. Roberts RG, Gask L, Arndt B, Bower P, Dunbar J, van der Feltz-Cornelis CM, Gunn J, Anderson MI. Depression and diabetes: the role a nd impact of models of health care systems. J Affect Disord 2012;142(Suppl):S80-8.
3. Glassman A, Shapiro PA, Ford DE, Culpepper L, Finkel MS, Swenson JR, Bigger JT, Rollman BL,Wise TN. Cardiovascular health and depression. J Psychiatr Pract 2003;9:409-21.
4. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk facto r for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-15.
5. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-92.
6. Schachinger H,WeinbacherM, Kiss A, Ritz R, LangewitzW. Cardiovascular indices of peripheral and central sympathetic activation. Psychosom Med 2001;63:788-96.
7. Rosenblueth A, Freeman NE. The reciprocal innervation in reflex changes of heart rate. Am J Physiol 1931;98:430-4.
8. Bern tson GG, Cacioppo JT, Binkley PF, Uchino BN, Quigley KS, Fieldstone A. Autonomic cardiac control. III. Psychological stress and cardiac response in autonomic space as revealed by pharmacological blockades. Psychophysiology 199 4;31:599-608.
9. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the A RIC study. Circulation 2000; 102:1239-44.
10. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004;26:637-44.
11. Tsuji H, Larson MG, Venditti FJ Jr., Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996;94:2850-5.
12. Ko SH, Song KH, Park SA, Kim SR, Cha BY, Son HY,Moon KW, Yoo KD, Park YM, Cho JH, Yoon KH, Ahn YB. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med 2008;25:1171-7.
13. Licht CM, de Geus EJ, Penninx BW. Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab 2013;98:2484-93.
14. Kemp AH, Quintana DS, GrayMA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment o n heart rate variability: a review and meta-Analysis. Biol Psychiatry 2010;67:1067-74.
15. Lehofer M, Moser M, Hoehn-Saric R, McLeod D, Liebmann P, Drnovsek B, Egner S, Hildebrandt G, Zapotoczky HG.Major depression and cardiac autonomic control. Biol Psychiatry 1997;42:914-9.
16. Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biol Psychiatry 2007;74:200-11.
17. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 2008;65:1358-67.
18. Licht CM, de Geus EJ, van Dyck R, Penninx BW. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry 2010;68:861-8.
19. Licht CM, PenninxBW, de Geus EJ. Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study. Neuropsychopharm acology 2012;37:2487-95.
20. KempAH, Quintana DS,Malhi GS Effects of serotonin reuptake inhibitors on heart rate variability:methodological issues, medical comorbidity, and clinical relevance. Biol Psychiatry 2011 69:e25-6.
21. Terhardt J, Lederbogen F, Feuerhack A, Hamann-Weber B, Gilles M, Schilling C, Lecei O, Deuschle M. Heart rate variability during antidepressant treatment with venlafaxin e and mirtazapine. Clin Neuropharmacol 2013;36:198-202.
22. Botek M, Stejskal P, Krejci J, Jakubec A, Gaba A. Vagal threshold determination. Effect of age and gender. Int J Sports Med 2010;31:768-72.
23. Fr ied LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin JM. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998;279:585-92.
24. Penninx BW, Guralnik JM, Mendes de Leon CF, Pahor M, Visser M, Corti MC, Wallace RB. Cardiovascular events and mortality in newly and chronically depressed persons 70 years of age. Am J Cardiol 1998 ;81:988-94.
25. van der Kooy KG, van Hout HP, van Marwijk HW, de Haan M, Stehouwer CD, Beekman AT. Differences in heart rate variability between depressed and non-depressed elderly. Int J Ger iatr Psychiatry 2006;21:147-50.
26. Vasudev A, O'Brien JT, Tan MP, Parry SW, Thomas AJ. A study of orthostatic hypotension, heart rate variability and baroreflex sensitivity in late-life depressio n. J Affect Disord 2011;131:374-8.
27. Gehi A, Mangano D, Pipkin S, Browner WS, Whooley MA. Depression and heart rate variability in patients with stable coronary heart disease: findings fro m the Heart and Soul Study. Arch Gen Psychiatry 2005;62:661-6.
28. Jindal RD, Vasko RC Jr., Jennings JR, Fasiczka AL, ThaseME, Reynolds CF III. Heart rate variability in depressed elderly. Am J Geriatr Psychiatry 2008;16:861-6.
29. de Jonge P, Mangano D,Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronar y heart disease: findings from the Heart and Soul Study. Psychosom Med 2007; 69:735-9.
30. Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol 2012;98:99-143.
31. Delaloye C, Moy G, de Bilbao F, Baudois S, Weber K, Hofer F, Ragno PC, Donati A, Canuto A, Giardini U, von Gunten A, Stancu RI, Lazeyras F, Millet P, Scheltens P, Giannakopoulos P, Gold G. Neuroanatomical and neuropsychological features of elderly euthymic depressed patients with early-And late onset. J Neurol Sci 2010;299:19-23.
32. Alexopoulos GS, Meyers BS, Young RC, Campbell S, SilbersweigD, CharlsonM. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-22.
33. Asplin BR, White RD. Subarachnoid hemorrhage: atypical presentation associated with rapidly changing cardiac arrhythmias. Am J Emerg Med 1994;12:370-3.
34. Khechi nashvili G, Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 2002;14:67-76.
35. Korpelainen JT, Sotaniemi KA, Suominen K, Tolonen U, Myllyla VV. Cardiovascular autonomic reflexes in brain infarction. Stroke 1994;25:787-92.
36. Comijs HC, van Marwijk HW, van der Mast RC, Naarding P,OudeVoshaar RC, BeekmanAT, BoshuisenM ,Dekker J, Kok R, deWaalMW, Penninx BW, StekML, Smit JH. The Netherlands study of depression in older persons (NESDO); a prospective cohort study. BMC Res Notes 2011;4:524.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington: American Psychiatric Association; 2001.
38. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84.
39. de Geus EJ, Willemsen GH, Klaver CH, van Doornen LJ. Ambulatory measurement of respiratory sinus arrhythmia and respiration rate. Biol Psychol 1995;41:205-27.
40. Willemsen GH, de Geus EJ, Klaver CH, van Doornen LJ, Carroll D. Ambulatory monitoring of the impedance cardiogram. Psychophysiology 1996;33:184-93.
41. Sherwood A, All en MT, Fahrenberg J, Kelsey RM, Lovallo WR, van Doornen LJ. Methodological guidelines for impedance cardiography. Psychophysiology 1990;27:1-23.
42. Mezzacappa ES, Kelsey RM, Katkin E S. The effects of epinephrine administration on impedance cardiographic measures of cardiovascular function. Int J Psychophysiol 1999;31:189-96.
43. Nelesen RA, Shaw R, Ziegler MG, Dimsdale JE. Impedance cardiography-derived hemodynamic responses during baroreceptor testing with amyl nitrite and phenylephrine: a validity and reliability study. Psychophysiology 1999;36:105-8.
44. Cacioppo JT, Ber ntson GG, Binkley PF, Quigley KS, Uchino BN, Fieldstone A. Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology 1994;31:586-98.
45. .Barton DA, Dawood T, Lambert EA, EslerMD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: identifying those at increa sed cardiac risk? J Hypertens 2007;25:2117-24.
46. Wallin BG. Sympathetic nerve activity underlying electrodermal and cardiovascular reactions in man. Psychophysiology 1981;18:470-6.
47. Goedhart AD, van der Sluis S, Houtveen JH,Willemsen G, de Geus EJ. Comparison of time and frequency domain measures of RSA in ambulatory recordings. Psychophysiology 2007; 44(2):203-15.
48. Anrep GV, Pascual W, Rössler R. Respiratory variations in heart rate. II. The central mechanism of the sinus arrhythmia and the inter-relationship between central and reflex mechanisms. Proc R Soc Lon B Biol Sci 1936;119:230.
49. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ. Assessment of autonomic function in humans by heart rate sp ectral analysis. Am J Physiol 1985;248:H151-3.
50. Quigley KS, Berntson GG. Autonomic origins of cardiac responses to nonsignal stimuli in the rat. Behav Neurosci 1990;104:751-62.
51. Kannel WB,Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82:2N-9.
52. Whang W, Peacock J, Soto AV, Borda T, Bhatt AB, Richardson SI, Burg M, Davidson KW. Relationship between premature ventricular complexes and depressive symptoms in non-ST-elevation acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2013;2:61-7.
53. World Health Organisation and Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification. 2007.
54. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996;26:477-86.
55. Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, Macgillivray S. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev 2009;CD007954.
56. Calat i R, Salvina SM, Balestri M, Marsano A, De Ronchi D, Aguglia E, Serretti A. Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. J Affect Disord 2013;147:1-8.
57. Furukawa TA, Streiner DL, Young LT. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev 2002;(1):CD001026.
58. Khan A, Faucett J, Lichtenberg P, Kirsch I, BrownWA.A systematic review of comparative efficacy of treatments and controls for depression. PLoS One 2012;7:e41778.
59. Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. Design makes a difference: a meta-Analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008;16:65-73.
60. Gr ossman P, Karemaker J, Wieling W. Prediction of tonic parasympathetic cardiac control using respiratory sinus arrhythmia: the need for respiratory control. Psychophysiology 1991;28:201-16.
61. Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport 2000;71(2 suppl):S114-20.
62. Berntson GG, Cacioppo JT, Quigley KS. Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. Psychophysiology 1993; 30:183-96.
63. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiolo gy Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996 93 1043-65.
64. Guinjoan SM, de Guevara MS, Correa C, Schauffele SI, Nicola-Si ri L, Fahrer RD, Ortiz-Fragola E,Martinez-Martinez JA, Cardinali DP. Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes. J Psychosom Res 2004;56:83-8.
65. Guinjoan SM, Castro MN, Vigo DE,Weidema H, Berbara C, Fahrer RD, Grancelli H, Nogues M, Leiguarda RC, Cardinali DP. Depressive symptoms are related to decreased lowfrequency heart rate variability in older adults with decompensated heart failure. Neuropsychobiology 2007;55:219-24.
66. Vigo DE, Nicola SL, Ladron De Guevara MS, Martinez-Martinez JA, Fahrer RD, Cardinali DP, Masoli O, Guinjoan SM. Relation of depression to heart rate nonlinear dynamics in patients > or =60 years of age with recent unstable angina pectoris or acute myocardial infarction. Am J Cardiol 2004; 93:756-60.
67. Licht CM, Penninx BW, de Geus EJ. To include or not to include A response to the meta-Analysis of heart rate variability and depression. Biol Psychiatry 2011;69:e1-4.
68. van der Kooy KG, van Hout HP, van Marwijk HW, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:613-26
69. Lic ht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW. Increased sympathetic and decreased parasympathetic activity rather than changes in h ypothalamic-pituitary-Adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010;95:2458-66.
70. Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van Dyck R, Penninx BW. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009;53:631-8.
71. Rahman I, Humphreys K, Bennet AM, Ingelsson E, Pedersen NL, Magnusson PK. Clinical depression, antidepressant use and risk of future cardiovascular disease. Eur J Epidemiol 2013;28:589-95.
72. Hamer M, Batty GD, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J 2011;32 (4):437-42.
73. Kimmel SE, Schelleman H, Be rlin JA, Oslin DW, Weinstein RB, Kinman JL, SauerWH, Lewis JD. The effect of selective serotonin re-uptake inhibitors on the risk ofmyocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol 2011;72:514-7.
74. Meier CR, Schlienger RG, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol 2001;52: 179-84 .
75. O'Connor CM, JiangW, Kuchibhatla M, Mehta RH, Clary GL, CuffeMS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR. Antidepressant use, depression, and survival in patients with heart failure.Arch Intern Med 2008;168:2232-7.
76. Pizzi C, Rutjes AW, Costa GM, Fontana F, Mezzetti A, Manzoli L. Meta-Analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 2011;107:972-9.
77. Tata LJ, West J, Smith C, Farrington P, Card T, Smeeth L, Hubbard R. General population based study of the impact of tri cyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005; 91:465-71.